26 Jun 2018

BRITISH COLUMBIA RESEARCHERS PRODUCE FIRST ANGIOPLASTY-READY SMART STENT

Vascular stents are some of the most commonly implanted medical devices, keeping millions of arteries open to uninterrupted blood flow. Though they tend to work well at first, too many end up being re-stenosed by new deposits of plaque and scar tissue often forms in the vicinity, blocking blood flow

0
26 Jun 2018

VENA CAVA FILTERS TO SEE DOUBLE-DIGIT CAGR ANNUAL GROWTH

The global inferior vena cava filters (IVCFs)market is expected to grow at a compounded annual growth rate (CAGR) of more than 11 percent during the period 2018-2022, according to a new 126-page market research study (SKU: IRTNTR21662) published early this year by Technavio. A free sample report or the full

0
24 Jun 2018

JUNE VTN REPORT

SURMODICS BUYS EMBOLITECH’S THROMBECTOMY PLATFORM, TECHNOLOGY, ASSETS FOR $5 MILLION Eden Prairie, Minn.-based SurModics has acquired Embolitech’s thrombectomy platform and associated intellectual property in a deal worth $5 million up front, with additional payments based on regulatory milestones. The technology platform acquired May 14 is designed for use in the peripheral

0
24 Jun 2018

INTACT VASCULAR OFFERS TOBA BTK DATA

Intact Vascular Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, has praised the publication of the Tack Optimized Balloon Angioplasty Below the Knee (TOBA BTK) clinical trial results in the current issue of Catheterization and Cardiovascular Intervention. This multi-center pilot study focused on collecting data supporting

0
21 Jun 2018

MOST VENOUS DISEASE CAN BE CLASSIFIED AS COSMETIC

      By Ronald Bush, MD, FACS In 1992, I left a busy practice of thoracic and vascular surgery and began the in-office treatment of varicose veins. At that time, high ligation and stripping using tumescent with ultra sound guided assistance was our treatment of choice for saphenous insufficiency.

0
13 Jun 2018

CASE STUDY: MANAGING PERSISTENT SWELLING AFTER ENDOVENOUS ABLATION

  By Tim Crawlield I have practiced phleboloby for six years and I learned early in my career that patients with swelling in the lower extremities — swelling that cannot be contained by elastic graduated compression stockings — do not benefit from endovenous ablations. My general rule of thumb is

0
13 Jun 2018

2018 RESEARCH SUMMIT: WORK BEGINS TO ANALYZE DATA IN RAPIDLY EXPANDING ACP PRO VENOUS REGISTRY

By Vanessa Salvia Contributing Editor Anticipation was high for many members of the phlebology community going into an April 21 closed-door research summit held alongside the International Vein Congress in Miami, convened to discuss how to make the most of the American College of Phlebology’s Patient Recorded Outcome Venous Registry,

0
07 Jun 2018

OPTALYSE PE: BTG RESULTS REINFORCE SAFETY, EFFICACY OF SHORTER, LOWER DOSE EKOS THERAPY FOR PE

BTG plc highlighted OPTALYSE PE one-year trial results, presented at the International Society on Endovascular Therapy in Florida in February. The findings confirm that bilateral pulmonary embolism (PE) patients treated in as little as two hours with a total tissue plasminogen activator (tPA) dose as low as 8mg continue to

0
29 May 2018

INTACT VASCULAR SPONSORS SYMPOSIUM ON POST-ANGIOPLASTY DISSECTIONS MAY 31

Intact Vascular Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, announced May 29 the schedule of key presentations that will be featured during a symposium sponsored together with Philips at the 19th Annual New Cardiovascular Horizons (NCVH) Conference  in New Orleans on May 31. Post-Percutaneous Transluminal Angioplasty (“PTA”)

0
01 May 2018

ACP RELOCATING TO CHICAGO IN JUNE; POSITIONING ITSELF AS VENOUS, LYMPHATIC ADVOCACY LEADER

After 30 years in San Leandro, Calif., The American College of Phlebology (ACP) is relocating its headquarters to Chicago. The move is expected to be complete by the end of June. The new address will be 434 W. Ontario St., Suite 200, Chicago, IL, 60654. This move is one of

0